[Federal Register: July 2, 2004 (Volume 69, Number 127)]
[Notices]
[Page 40381-40384]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02jy04-59]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
HIV/AIDS Surveillance: Development and Evaluation of Education
Materials and Tools Used To Ascertain Risk Factor Information for HIV/
AIDS Surveillance
Announcement Type: Supplement.
Funding Opportunity Number: 04017 Supplement.
Catalog of Federal Domestic Assistance Number: 93.944.
Application Deadline: August 2, 2004.
I. Funding Opportunity Description
Authority: This program is authorized under the Public Health
Service Act Sections 301 (42 U.S.C. 241); and 318B (42 U.S.C. 247c-
2), as amended.
Purpose: The purpose of the supplement is to develop and evaluate
educational materials and tools to assist in ascertaining risk factor
information by HIV/AIDS surveillance programs funded by the HIV
Incidence and Case Surveillance Branch in the Division of HIV/AIDS
Prevention at the Centers for Disease Control and Prevention. The
ultimate goal is for surveillance areas to better ascertain risk factor
information in an effort to reduce the proportion of HIV/AIDS cases
reported to the national surveillance system without transmission
category information.
The decreasing proportion of transmission category information at
the national level continues to be a problem. Transmission category
information is critical to allocating resources and developing
effective prevention activities. Funded areas will develop educational
materials and tools to assist surveillance staff, health care partners
and providers, and others reporting or abstracting risk factor
information for surveillance purposes to obtain more complete
ascertainment of risk factor information at the local level. There is
also a need to evaluate these materials and tools to determine whether
they are useful in improving completeness of ascertainment of risk
factor information and if so, what information sources produced the
highest yields. This information will help to inform the HIV/AIDS
Surveillance Guidelines revisions. The development and evaluation of
materials and tools is intended to take place over a two year period.
The evaluation results are intended to immediately inform the HIV/AIDS
surveillance program in order to make timely programmatic decisions.
Year one funding is intended for formative assessment of barriers to
reporting. Year two is intended for materials and tools development and
testing of materials and tools. This program addresses the ``Healthy
People 2010'' focus area(s) for HIV.
Status of the ongoing award: PA 04017, HIV/AIDS Surveillance
Cooperative Agreement, is in the 1st year of a 3-year project period.
Federal and/or non-Federal investment in that award: In FY 2004,
$45,434,343 was awarded to 65 state, territorial, and local health
departments.
The impact on the objectives of the affected program of not making
the additional or supplemental award: A principal goal of the HIV/AIDS
Cooperative agreement is to better ascertain risk factor information in
an effort to reduce the proportion of HIV/AIDS cases reported to the
national surveillance system without transmission category information.
Without this supplement, we will be unable to develop and evaluate
educational materials and tools to assist in ascertaining risk factor
information by HIV/AIDS surveillance programs. The development and
evaluation of materials and tools is intended to take place over a two
year period. The evaluation results are intended to immediately inform
the HIV/AIDS surveillance program in order to make timely programmatic
decisions. Year one funding is intended for formative assessment of
barriers to reporting. During year two, the educational materials and
tools will be developed and tested.
Measurable outcomes of the program will be in alignment with one
(or more) of the following performance goal(s) for the National Center
for HIV STD and TB Prevention (NCHSTP): Strengthen the capacity
nationwide to monitor the epidemic, develop and implement effective HIV
prevention interventions and evaluate prevention programs.
Activities
Awardee activities for this program are as follows:
(1) Participate in a conference call (within one month of award)
with CDC and other awardees to begin to develop a project plan and 2-
year time line;
[[Page 40382]]
(2) Collaborate with CDC staff to develop instruments to assess
barriers to reporting and collect information on barriers to reporting;
(3) Collaborate with CDC staff to select control and evaluation
sites within each area;
(4) From evaluation sites, collect risk factor information using
standard public health surveillance methods such as chart reviews,
source of information as well as other relevant information utilizing
the educational materials and tools in a timeframe determined by the
CDC;
(5) Report information collected in item (4) in a format and
timeframe determined by the CDC;
(6) Provide qualitative feedback related to the feasibility and
acceptability of the educational materials and tools to the CDC in a
format and timeframe determined by the CDC; and
(7) Maintain a secure environment to protect the security and
confidentiality of data obtained in these evaluation activities.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring. CDC
activities include:
(1) Participate in a conference call (within one month of award)
with awardees to begin to develop a project plan and 2-year time line;
(2) Collaborate with awardees to develop instruments to assess
barriers to reporting;
(3) Collaborate with awardees to select control and evaluation
sites within each area;
(4) Determine timeframe for the collection and reporting of data by
the awardees to the CDC;
(5) Maintain a secure environment to protect the security and
confidentiality of data obtained in these evaluation activities; and
(6) Analyze data and disseminate project results.
II. Award Information
Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities Section above.
Fiscal Year Funds: 2004.
Approximate Total Funding: $240,000.
Approximate Number of Awards: 2-3.
Approximate Average Award: $80,000.
Anticipated Award Date: September 2004.
Budget Period Length: Budget periods will coincide with budget
periods for PA04017 funding. The current budget period ends December
31, 2004.
Project Period Length: 2 years 3 months.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.
III. Eligibility Information
III.1. Eligible Applicants
Surveillance areas should have a large number of cases reported
without risk factor information available over a short time period in
order to provide sufficient statistical power.
Eligible applicants are state or territorial health departments or
directly funded city health departments currently engaged in HIV/AIDS
surveillance funded through Program Announcement 04017 with at least
5,000 HIV cases reported to CDC in 2002 as reported in the HIV/AIDS
Surveillance Report (2002) and with at least 800 cases initially
reported without risk factor information.
Eligible applicants also must have the legal authority to access
health care records, consistently and rapidly contact health care
providers as part of routine HIV surveillance, and have implemented HIV
laboratory- and provider-based reporting since at least January 1,
2001.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
Note: Title 2 of the United States Code Section 1611 states that
an organization described in Section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
IV. Application and Submission Information
IV.1. Address to Request Application Package
To apply for this funding opportunity use application form CDC
1246. Application forms and instructions are available on the CDC web
site, at the following Internet address: http://www.cdc.gov listed under
funding. If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Submission
Application: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
Maximum number of pages: 10 If your narrative exceeds the
page limit, only the pages within the page limit will be reviewed.
Font size: 12 point unreduced.
Double spaced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Held together only by rubber bands or metal clips; not
bound in any other way.
Your narrative should address activities to be conducted over the
entire project period, and must include the following items in the
order listed:
(1) Participate in a conference call (within one month of award)
with CDC and other awardees to begin to develop a project plan and 2-
year time line;
(2) Collaborate with CDC staff to develop instruments to assess
barriers to reporting and collect information on barriers to reporting;
(3) Collaborate with CDC staff to select control and evaluation
sites within each area;
(4) From evaluation sites, collect risk factor information using
standard public health surveillance methods such as chart reviews,
source of information as well as other relevant information utilizing
the educational materials and tools in a timeframe determined by the
CDC;
(5) Report information collected in item (4) in a format and
timeframe determined by the CDC;
(6) Provide qualitative feedback related to the feasibility and
acceptability of the educational materials and tools to the CDC in a
format and timeframe determined by the CDC; and
(7) Maintain a secure environment to protect the security and
confidentiality of data obtained in these evaluation activities.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
If your
[[Page 40383]]
application form does not have a DUNS number field, please write your
DUNS number at the top of the first page of your application, and/or
include your DUNS number in your application cover letter.
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Times
Application Deadline Date: August 2, 2004.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you send your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery of the application by the closing date
and time. If CDC receives your application after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carriers guarantee. If the documentation
verifies a carrier problem, CDC will consider the application as having
been received by the deadline.
This announcement is the definitive guide on application submission
address and deadline. It supersedes information provided in the
application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that your application did not meet the
submission requirements.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: 770-488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for applications to be
processed and logged.
IV.4. Intergovernmental Review of Applications
Your application is subject to Intergovernmental Review of Federal
Programs, as governed by Executive Order (EO) 12372. This order sets up
a system for state and local governmental review of proposed federal
assistance applications. You should contact your state single point of
contact (SPOC) as early as possible to alert the SPOC to prospective
applications, and to receive instructions on your state's process.
Click on the following link to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html
.
IV.5. Funding Restrictions
Restrictions which must be taken into account while writing your
budget are as follows:
None
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.
IV.6. Other Submission Requirements
Application Submission Address: Submit the original and two hard
copies of your application by mail or express delivery service to:
Technical Information Management--PA 04017 Supplemental, CDC
Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.
Applications may not be submitted electronically at this time.
V. Application Review Information
V.1. Criteria
You are required to provide measures of effectiveness that will
demonstrate the accomplishment of the various identified objectives of
the cooperative agreement. Measures of effectiveness must relate to the
performance goals stated in the ``Purpose'' section of this
announcement. Measures must be objective and quantitative, and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
Your application will be evaluated against the following criteria:
(1) The extent to which the applicant describes its ability to
collaborate with CDC and other awardees on projects with a quick turn
around time. (20 Points)
(2) The extent to which the applicant demonstrates its ability to
develop realistic project plans and time lines and follow through on
their completion. (20 Points)
(3) The extent to which the applicant describes its ability to
develop instruments to assess barriers to reporting, or other
surveillance activities, and to collect information on barriers to
these activities. (20 Points)
(4) The extent to which the applicant describes past, current, and
proposed collaboration with: the relevant HIV/AIDS organizations and
agencies within the reporting area, CDC, and other states or national
organizations involved in coordinating and assuring the quality,
completeness, and accuracy of HIV/AIDS surveillance data and can
demonstrate the understanding of the importance of following a standard
protocol for data collection. (15 Points)
(5) The extent to which the applicant can maintain a secure
environment to protect the security and confidentiality of data
obtained in these evaluation activities. (15 Points)
(6) The extent to which proposed staffing, organizational
structure, staff experience and background, and job descriptions and
curricula vitae for both proposed and current staff indicate the
ability to carry out the anticipated activities. (10 Points)
(7) The budget is reasonable, clearly justified, consistent with
the demonstrated need and proposed activities, and likely to lead to
success of the planned activities. (Reviewed, but not scored)
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office staff, and for responsiveness by NCHSTP. Incomplete
applications and applications that are non-responsive to the
eligibility criteria will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the evaluation criteria listed in the
criteria section above.
V.3. Anticipated Announcement and Award Dates
September 1, 2004.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
[[Page 40384]]
VI.2. Administrative and National Policy Requirements
45 CFR Part 74 and Part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-4 HIV/AIDS Confidentiality Provisions.
AR-7 Executive Order 12372.
AR-8 Public Health System Reporting Requirements.
AR-9 Paperwork Reduction Act Requirements.
AR-11 Healthy People 2010.
AR-14 Accounting System Requirements.
AR-16 Security Clearance Requirement.
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
VII. Agency Contacts
For general questions about this announcement, contact: Technical
Information Management Section, CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2700.
For program technical assistance, contact: Ron Sanders, Program
Consultant, National Center for HIV, STD and TB Prevention, Division of
HIV AIDS Prevention, 1600 Clifton Road, NE Mail stop E-47, Atlanta, GA
30333, Telephone: 404-639-4678, E-mail: RLS5@cdc.gov.
For financial, grants management, or budget assistance, contact:
Kang Lee, Grants Management Specialist, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-
2733, E-mail: kil8@cdc.gov.
Dated: June 28, 2004.
Alan Kotch,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-15070 Filed 7-1-04; 8:45 am]
BILLING CODE 4163-18-P